Atherosclerosis

Last Updated: May 12, 2025

Atherosclerosis is the buildup of lipid-rich plaque on arteries’ interior lining. While symptomless early on, it can lead to artery blockage and increased clot formation, which can cause a wide range of serious diseases, most commonly coronary heart disease and stroke. Lifestyle factors, such as poor diet, little exercise, and smoking, can be integral in the progression of atherosclerosis and its associated diseases.

Atherosclerosis falls under theCardiovascular Healthcategory.

What is atherosclerosis?

Atherosclerosis is the buildup of fatty plaque on the interior lining of medium-sized and large-sized arteries, leading to damage, inflammation, hardening, and narrowing of the arteries, which increases the risk of clotting and various diseases. It is a specific type of arteriosclerosis, distinct from the broader term that refers to general thickening and stiffening of blood vessels.

What are the main signs and symptoms of atherosclerosis?

Atherosclerosis is typically asymptomatic until it leads to other cardiovascular diseases, such as coronary artery disease. It can be assessed using various methods, including angiography, coronary calcium scans, the ankle-brachial test, and ultrasonography, and angiography is the most invasive option.

How is atherosclerosis diagnosed?

Atherosclerosis is typically not diagnosed directly in its preclinical stage but may be identified through imaging or clinical criteria once it manifests. Diagnosis can also be inferred from risk factors such as high blood pressure, LDL-C levels, age, and smoking behaviors.

What are some of the main medical treatments for atherosclerosis?

Medical treatments for atherosclerosis vary based on the disease's progression and typically focus on managing major risk factors like high cholesterol and high blood pressure with medications such as statins and antihypertensives. These treatments are often combined with lifestyle changes, which are also crucial in managing the condition.

Have any supplements been studied for atherosclerosis?

Yes, several supplements have been studied for their effect on atherosclerosis and its biomarkers, and more research has focused on biomarkers like LDL-C and blood pressure. Some of the supplements examined include omega-3 and omega-6 fatty acids, garlic, plant sterols, flavanols, fiber, and antioxidant vitamins like vitamin C.

How could diet affect atherosclerosis?

Diet significantly influences atherosclerosis by affecting risk factors like obesity, high cholesterol, high blood pressure, and diabetes. A diet that is rich in fruits, vegetables, legumes, nuts, whole grains, and fish can lower the risk of atherosclerotic diseases, and replacing saturated fats with healthier fats and reducing processed meats and refined carbohydrates may also be beneficial.

Are there any other treatments for atherosclerosis?

Quitting smoking and engaging in regular aerobic exercise are crucial lifestyle changes that can significantly affect atherosclerosis. Current guidelines recommend at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity each week.

What causes atherosclerosis?

Atherosclerosis begins with damage to the interior lining of medium and large arteries, often due to high pressure, which leads to the trapping and oxidation of fats, primarily low-density lipoprotein. This process attracts white blood cells, particularly macrophages, which can become overwhelmed and transform into foam cells, thus contributing to plaque formation.

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Atherosclerosis
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

References
  1. ^Hall JE, Hall,ME, Guyton ACTextbook of Medical Physiology, 14th Edition; p. 862(2021)
  2. ^MedlinePlus: Atherosclerosis
  3. ^StatPearls: atherosclerosis
  4. ^Atherosclerosis: Diagnosis
  5. ^Atherosclerosis: Symptoms
  6. ^Donna K Arnett, Roger S Blumenthal, Michelle A Albert, Andrew B Buroker, Zachary D Goldberger, Ellen J Hahn, Cheryl Dennison Himmelfarb, Amit Khera, Donald Lloyd-Jones, J William McEvoy, Erin D Michos, Michael D Miedema, Daniel Muñoz, Sidney C Smith Jr, Salim S Virani, Kim A Williams Sr, Joseph Yeboah, Boback Ziaeian2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation.(2019 Sep 10)
  7. ^Joe W E Moss, Dipak P RamjiNutraceutical therapies for atherosclerosisNat Rev Cardiol.(2016 Sep)
  8. ^Gaemperli O, Liga R, Bhamra-Ariza P, Rimoldi ONicotine addiction and coronary artery disease: impact of cessation interventions.Curr Pharm Des.(2010)
  9. ^Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GSRelation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.N Engl J Med.(1986-Jan-16)
  10. ^Jan Borén, M John Chapman, Ronald M Krauss, Chris J Packard, Jacob F Bentzon, Christoph J Binder, Mat J Daemen, Linda L Demer, Robert A Hegele, Stephen J Nicholls, Børge G Nordestgaard, Gerald F Watts, Eric Bruckert, Sergio Fazio, Brian A Ference, Ian Graham, Jay D Horton, Ulf Landmesser, Ulrich Laufs, Luis Masana, Gerard Pasterkamp, Frederick J Raal, Kausik K Ray, Heribert Schunkert, Marja-Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lale Tokgozoglu, Alberico L Catapano, Henry N GinsbergLow-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelEur Heart J.(2020 Jun 21)
  11. ^King TCCardiovascular PathologyElsevier's Integrated Pathology.(2007 pp. 169-195)
  12. ^Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano ALLow-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEur Heart J.(2017 Aug 21)
  13. ^Goldstein JL, Brown MSA century of cholesterol and coronaries: from plaques to genes to statins.Cell.(2015-Mar-26)
  14. ^Libby PThe changing landscape of atherosclerosis.Nature.(2021-04)
  15. ^Shapiro MD, Fazio SApolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.F1000Res.(2017)
  16. ^Steinberg D, Witztum JLOxidized low-density lipoprotein and atherosclerosis.Arterioscler Thromb Vasc Biol.(2010-Dec)
  17. ^Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, Hayashi J, Schaefer EJSmall Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.J Atheroscler Thromb.(2020-Oct-01)
  18. ^Göran K Hansson, Peter LibbyThe immune response in atherosclerosis: a double-edged swordNat Rev Immunol.(2006 Jul)
  19. ^Goldberg IJ, Sharma G, Fisher EAAtherosclerosis: Making a U Turn.Annu Rev Med.(2020-01-27)
  20. ^Parsons C, Agasthi P, Mookadam F, Arsanjani RReversal of coronary atherosclerosis: Role of life style and medical management.Trends Cardiovasc Med.(2018-11)
  21. ^Gupta SK, Sawhney RC, Rai L, Chavan VD, Dani S, Arora RC, Selvamurthy W, Chopra HK, Nanda NCRegression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients--Mount Abu Open Heart TrialIndian Heart J.(2011 Sep-Oct)
  22. ^Jimenez-Torres J, Alcalá-Diaz JF, Torres-Peña JD, Gutierrez-Mariscal FM, Leon-Acuña A, Gómez-Luna P, Fernández-Gandara C, Quintana-Navarro GM, Fernandez-Garcia JC, Perez-Martinez P, Ordovas JM, Delgado-Lista J, Yubero-Serrano EM, Lopez-Miranda JMediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial.Stroke.(2021-11)
  23. ^, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZCardiovascular effects of intensive lifestyle intervention in type 2 diabetes.N Engl J Med.(2013-Jul-11)
  24. ^Raitakari O, Pahkala K, Magnussen CGPrevention of atherosclerosis from childhood.Nat Rev Cardiol.(2022-08)
Examine Database References
  1. Serum Platelets - Joanna J Samulak, Angelika K Sawicka, Emilia Samborowska, Robert A OlekPlasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged WomenNutrients.(2019 Jun 13)
  2. High-density lipoprotein (HDL) - Castaño G, Más R, Fernández JC, Illnait J, Fernández L, Alvarez EEffects of policosanol in older patients with type II hypercholesterolemia and high coronary riskJ Gerontol A Biol Sci Med Sci.(2001 Mar)
  3. High-density lipoprotein (HDL) - Gutierrez AD, Duran-Valdez E, Robinson I, de Serna DG, Schade DSDoes short-term vitamin C reduce cardiovascular risk in type 2 diabetes?Endocr Pract.(2013 Sep-Oct)
  4. High-density lipoprotein (HDL) - AIM-HIGH Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub WNiacin in patients with low HDL cholesterol levels receiving intensive statin therapyN Engl J Med.(2011 Dec 15)
  5. High-density lipoprotein (HDL) - Yang L, Zhu W, Zhang X, Zhou X, Wu W, Shen TEfficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.Phytomedicine.(2023-Apr)
  6. High-density lipoprotein (HDL) - Bersch-Ferreira ÂC, Stein E, Waclawovsky G, da Silva LR, Machado RHV, Weschenfelder C, Figueiro MF, Suzumura EA, Santos RHN, Duarte GBS, Rogero MM, de Abreu-Silva EO, Cavalcanti AB, Marcadenti AEffect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials.Eur J Nutr.(2024 Jul 5)
  7. Atherosclerotic Signs - Koscielny J, Klüssendorf D, Latza R, Schmitt R, Radtke H, Siegel G, Kiesewetter HThe antiatherosclerotic effect of Allium sativumAtherosclerosis.(1999 May)
  8. Atherosclerotic Signs - Wang S, Chen Y, Wang R, Ma B, Wang Z, Tang G, Wang S, He Y, Qu LEffectiveness of red yeast rice on carotid atherosclerosis: A systematic review and meta-analysis.Front Pharmacol.(2022)
  9. Atherosclerotic Signs - Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo YEffect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.Atherosclerosis.(2012-Jun)
  10. C-Reactive Protein (CRP) - Koushki M, Dashatan NA, Meshkani REffect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Clin Ther.(2018-Jul)
  11. Microcirculation - Suter A, Niemer W, Klopp RA new ginkgo fresh plant extract increases microcirculation and radical scavenging activity in elderly patientsAdv Ther.(2011 Dec)
  12. Pulse Wave Velocity - Katayoshi T, Uehata S, Nakashima N, Nakajo T, Kitajima N, Kageyama M, Tsuji-Naito KNicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.Sci Rep.(2023-Feb-16)